Latest recalls — page 142
Older notices, newest first.
-
Class II · 7 months ago
Cipla USA, Inc. Lanreotide Injection, 120 mg*/0.5 mL recall: Lack of Assurance of Sterility: Due to an FDA observation at the contract
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
-
Class II · 7 months ago
Fresenius Kabi USA, LLC 0.9% Sodium Chloride Injection, USP 900 mg per 100 mL , 1 recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 7 months ago
Teva Pharmaceuticals USA, Inc Isotretinoin Capsules, USP, 30 mg recall: Superpotent and Subpotent
Superpotent and Subpotent
-
Class II · 7 months ago
GE Healthcare Ireland Limited GE Healthcare Omnipaque Injection, 300 mg/mL recall: Presence of particulate matter
Presence of particulate matter
-
Class II · 7 months ago
Fagron Compounding Services Vancomycin HCL, 1 gram added to 250 mL recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
Class II · 7 months ago
Teva Pharmaceuticals USA, Inc Isotretinoin Capsules, USP, 40 mg recall: Superpotent and Subpotent
Superpotent and Subpotent
-
Class II · 7 months ago
Fresenius Kabi USA, LLC 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL 250 mL recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 7 months ago
Fresenius Kabi USA, LLC 0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 7 months ago
Fresenius Kabi USA, LLC 0.9% Sodium Chloride Injection, USP 0.9% 50 mL recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 7 months ago
Fagron Compounding Services norepinephrine Bitartrate recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
Class II · 7 months ago
Preferred Pharmaceuticals, Inc. Artificial Tears Lubricant Eye Drops recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 7 months ago
Viatris, Inc. Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · 7 months ago
Fresenius Kabi USA, LLC 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL 1 recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 7 months ago
Fresenius Kabi USA, LLC 5% Dextrose Injection, USP 5 g per 100 mL 100 mL in a 100 mL recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 7 months ago
Fresenius Kabi USA, LLC 5% Dextrose Injection, USP 12.5 g per 250 mL 250 mL in a 250 recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 7 months ago
Fagron Compounding Services norepinephrine Bitartrate recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
Class II · 7 months ago
Teva Pharmaceuticals USA, Inc Clonidine Transdermal System, USP, 0.3 mg/day recall: CGMP Deviations: use of an unapproved raw material
CGMP Deviations: use of an unapproved raw material
-
Class II · 7 months ago
Fresenius Kabi USA, LLC 5% Dextrose Injection, USP 2.5 g per 50 mL 50 mL in a 100 mL recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 7 months ago
Cipla USA, Inc. Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe recall: Lack of Assurance of Sterility: Due to an FDA observation at the contract
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
-
Class II · 7 months ago
GE Healthcare Ireland Limited GE Healthcare Omnipaque Injection, 350 mg/mL recall: Presence of particulate matter
Presence of particulate matter
-
Class II · 7 months ago
Fresenius Kabi USA, LLC 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL 100 mL recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 7 months ago
Fagron Compounding Services Vancomycin HCI, 1.25 grams added to 250 mL recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
Class II · 7 months ago
Teva Pharmaceuticals USA, Inc Clonidine Transdermal System, USP, 0.1 mg/day recall: CGMP Deviations: use of an unapproved raw material
CGMP Deviations: use of an unapproved raw material
-
Class II · 7 months ago
Fresenius Kabi USA, LLC 0.9% Sodium Chloride Injection, USP recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility